Stebėti
Nicola Casiraghi
Nicola Casiraghi
The Microsoft Research-University of Trento Centre for Computational and Systems Biology
Patvirtintas el. paštas cosbi.eu
Pavadinimas
Cituota
Cituota
Metai
Plasma AR and abiraterone-resistant prostate cancer
A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ...
Science translational medicine 7 (312), 312re10-312re10, 2015
4522015
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
H Beltran, A Romanel, V Conteduca, N Casiraghi, M Sigouros, ...
The Journal of clinical investigation 130 (4), 1653-1668, 2020
1512020
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
SM Tirier, JP Mallm, S Steiger, AM Poos, MHS Awwad, N Giesen, ...
Nature Communications 12 (1), 6960, 2021
732021
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer
D Nava Rodrigues, N Casiraghi, A Romanel, M Crespo, S Miranda, ...
Clinical Cancer Research 25 (2), 687-697, 2019
482019
Loop 7 of E2 enzymes: an ancestral conserved functional motif involved in the E2-mediated steps of the ubiquitination cascade
E Papaleo, N Casiraghi, A Arrigoni, M Vanoni, P Coccetti, L De Gioia
PloS one 7 (7), e40786, 2012
322012
Role of prion disease-linked mutations in the intrinsically disordered N-terminal domain of the prion protein
X Cong, N Casiraghi, G Rossetti, S Mohanty, G Giachin, G Legname, ...
Journal of chemical theory and computation 9 (11), 5158-5167, 2013
212013
Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model
P Lecca, N Casiraghi, F Demichelis
Frontiers in genetics 6, 162905, 2015
152015
Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.
H Beltran, A Romanel, N Casiraghi, M Sigouros, M Benelli, J Xiang, ...
Journal of Clinical Oncology 35 (15_suppl), 5011-5011, 2017
132017
Core biopsies from prostate cancer patients in active surveillance protocols harbor PTEN and MYC alterations
P Gandellini, N Casiraghi, T Rancati, M Benelli, V Doldi, A Romanel, ...
European Urology Oncology 2 (3), 277-285, 2019
122019
Single cell multi-omics analysis of chromothriptic medulloblastoma highlights genomic and transcriptomic consequences of genome instability
RG Parra, MJ Przybilla, M Simovic, H Susak, M Ratnaparkhe, JKL Wong, ...
bioRxiv, 2021.06. 25.449944, 2021
92021
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA
N Casiraghi, F Orlando, Y Ciani, J Xiang, A Sboner, O Elemento, G Attard, ...
Bioinformatics 36 (9), 2665-2674, 2020
92020
Atomistic insights into the regulatory mechanisms mediated by post-translational modifications: Molecular dynamics investigations
E Papaleo, N Casiraghi, A Arrigoni, V Ranzani
Current Physical Chemistry 2 (4), 344-362, 2012
72012
Plasma AR and abiraterone-resistant prostate cancer. Sci Transl Med. 2015; 7 (312): 312
A Romanel, D Gasi Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ...
5
A22 Medium-sized spiny neurons diversity in Huntington’s disease pathology
G Bergonzoni, D Ferrarini, A Savino, T Gillis, NA Casiraghi, S Geurs, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (Suppl 1), A8-A8, 2022
2022
P-060: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single cell transcriptomics
K Rippe, S Tirier, JP Mallm, S Steiger, A Poos, M Awwad, N Giesen, ...
Clinical Lymphoma Myeloma and Leukemia 21, S71-S72, 2021
2021
Circulating tumor DNA (ctDNA) to detect neuroendocrine prostate cancer genomic and DNA methylation changes.
H Beltran, A Romanel, V Conteduca, N Casiraghi, M Sigouros, ...
Journal of Clinical Oncology 38 (6_suppl), 8-8, 2020
2020
A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed …
AM Poos, JP Mallm, SM Tirier, N Casiraghi, H Susak, N Giesen, K Bauer, ...
Blood 134, 575, 2019
2019
Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma
SM Tirier, JP Mallm, N Casiraghi, H Susak, N Giesen, AM Poos, K Bauer, ...
Blood 134, 571, 2019
2019
Quantitative analyses to study tumor clones dynamics and tumor heterogeneity
N Casiraghi
University of Trento, 2017
2017
Tumor heterogeneity in castration resistant neuroendocrine prostate cancer from whole exome sequencing of circulating tumor DNA
H Beltran, A Romanel, N Casiraghi, M Sigouros, M Benelli, J Xiang, ...
CANCER RESEARCH 77, 2017
2017
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20